Regard vs Manus AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC healthcare AI clinical insights at $350M valuation Jul 2024 with 3M+ diagnoses surfaced and $50M+ incremental revenue for partners; $81.3M total ($61M Oak HC/FT Series B) serving Banner Health and Sentara competing with Nuance CDI.
About
Regard is a New York-based healthcare AI company — backed with $81.3 million in total funding including a $61 million Series B in July 2024 led by Oak HC/FT with Cedars-Sinai Health Ventures at a $350 million valuation, following a $15.3 million Series A in 2022 and $5 million seed in 2021 — providing health systems with an AI clinical insights platform that analyzes 100% of hospitalized patient medical record data to surface missed diagnoses to care teams, acting as an AI co-pilot for physicians that has surfaced 3 million+ diagnoses and generated $50+ million in incremental revenue for health system partners through improved documentation accuracy. Founded in 2019 by Eli Ben-Joseph, Nate Wilson, and Thomas Moulia (Stanford graduate students) and launched in 2021, Regard serves major health systems including Banner Health (33 acute care hospitals) and Sentara Health (12 hospitals).
General-purpose autonomous AI agent. $125M+ revenue run rate. Acquired by Meta for $2B+ (Dec 2025). Founded 2022, China/Singapore. MIT Innovators Under 35.
About
Manus AI is a general-purpose autonomous AI agent developed by Butterfly Effect Pte Ltd, founded in 2022 by Yichao "Peak" Ji and Xiao Hong. Relocated from China to Singapore (mid-2025). Launched March 6, 2025, autonomously handling complex tasks like market research, coding, data analysis, and content creation without human intervention.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.